ORAL LEUKOPLAKIA
Clinical trials for ORAL LEUKOPLAKIA explained in plain language.
Never miss a new study
Get alerted when new ORAL LEUKOPLAKIA trials appear
Sign up with your email to follow new studies for ORAL LEUKOPLAKIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug stop oral cancer before it starts?
Prevention OngoingThis study tests whether metformin, a drug used for diabetes, can prevent oral cancer in people with precancerous mouth lesions (leukoplakia or erythroplakia). About 26 participants took metformin to see if their lesions shrank or disappeared. The goal is to find a simple way to …
Matched conditions: ORAL LEUKOPLAKIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 17, 2026 08:04 UTC
-
Could a common diabetes drug stop oral cancer before it starts?
Prevention OngoingThis study tests whether metformin, a common diabetes drug, can prevent oral cancer in 34 people with precancerous white or red patches in the mouth. Participants take metformin to see if it can reverse or stop these patches from turning into cancer. The goal is to find a safe, l…
Matched conditions: ORAL LEUKOPLAKIA
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Prevention
Last updated May 17, 2026 08:03 UTC